World Alzheimer's Day 2020: Ending The Stigma Around Dementia

World Alzheimer's Day is an international campaign organised by Alzheimer's Disease International to raise awareness and highlight issues faced by people affected by dementia. It takes place every year on September 21st and is the focus of World Alzheimer's Month.

Dementia is one of the biggest challenges we face, with nearly 50 million people living with dementia worldwide. Yet 2 out of every 3 people globally believe there is little or no understanding of dementia in their countries.The impact of World Alzheimer's Month is growing, but the stigmatisation and misinformation that surrounds dementia remains a global problem. To tackle this challenge, we need to collaborate and share best practice with one another.

In support of this year’s theme – ‘Let’s talk about dementia’ - Elsevier presents a curated, open access collection of 25 journal articles and book chapters focused on challenging the fear and stigma associated with dementia.

Together, we can help people live well with dementia.


Neuroprotection in Autism, Schizophrenia and Alzheimer's Disease, 2020, Pages 245-272

This chapter addresses goal 3 by discussing novel therapeutics for Alzheimer's Disease.

Handbook of Sleep Disorders in Medical Conditions, 2019, Pages 253-276

This chapter addresses goal 3 by providing an overview of sleep disorders in dementia.

Physical Activity and the Aging Brain, Effects of Exercise on Neurological Function, 2017, Pages 141-150

This chapter addresses goal 3 by examining the role that exercise and physical activity play on Alzheimer’s Disease.

Environmental Psychology and Human Well-Being, Effects of Built and Natural Settings, 2018, Pages 365-386

This chapter addresses goal 3 by providing a better understanding of the way in which mental and physical well-being is affected by physical environments, along with insights into how the design of these environments might be improved to support better health outcomes.

The Immune System and Mental Health, 2018, Pages 483-515

This chapter addresses goal 3 by investigating the immune system to identify factors that can undermine and impair mental health, including Alzheimer’s Disease.

Alzheimer's Disease, Life Course Perspectives on Risk Reduction, 2016, Pages 57-73

This chapter addresses goal 3 by examining the prevalence and epidemiology of Alzheimer's Disease.

Genetics, Neurology, Behavior, and Diet in Dementia, The Neuroscience of Dementia, Volume 2, 2020, Pages 633-645

This chapter addresses goal 3 by examining the stigma that exists around dementia and how this has contributed to patient mistreatment, caregiver burnout, and inadequate research funding.

Better Living with Dementia, Implications for Individuals, Families, Communities, and Societies, 2018, Pages 247-264

This chapter addresses goal 3 by discussing the transformative actions that need to occur at each level of our social ecological model to support or result in comprehensive dementia care.

Biomarkers in Alzheimer's Disease, 2016, Pages 103-135

This chapter addresses goal 3 by providing an overview of genetic biomarkers and the risk of developing Alzheimer's Disease.

Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (Sixth Edition), Volume 1, 2020, Pages 283-297

This chapter addresses Goal 3 by discussing the genetic relationship between Alzheimer's disease and Down Syndrome.